We are live on
!
Find out more
Aristotle Capital Management Portfolio holdings
AUM
$47.8B
1-Year Est. Return
13.38%
This Fund
S&P 500
This Quarter
Est. Return
+6.36%
1 Year Est. Return
+13.38%
3 Year Est. Return
+48.4%
5 Year Est. Return
+59.36%
10 Year Est. Return
+297.67%
AUM
$14.4B
AUM Growth
+$1.54B
(+12%)
Cap. Flow
+$815M
Cap. Flow
% of AUM
5.65%
Top 10 Holdings %
Top 10 Hldgs %
30.74%
Holding
187
New
41
Increased
85
Reduced
20
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$307M |
| 2 |
Amgen
AMGN
|
+$120M |
| 3 |
East-West Bancorp
EWBC
|
+$111M |
| 4 |
Banco Bilbao Vizcaya Argentaria
BBVA
|
+$25.7M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$23.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$407M |
| 2 |
AbbVie
ABBV
|
+$82.9M |
| 3 |
FRC
First Republic Bank
FRC
|
+$64.4M |
| 4 |
Cameco
CCJ
|
+$2.13M |
| 5 |
Lennar Class A
LEN
|
+$1.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.4% |
| 2 | Healthcare | 16.03% |
| 3 | Technology | 12.85% |
| 4 | Energy | 9.37% |
| 5 | Industrials | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Apple
AAPL
$4.99T
| $677K | ﹤0.01% |
16,000
| – | – |
|
102
Berkshire Hathaway Class B
BRK.B
$1.11T
| $605K | ﹤0.01% |
3,050
| – | – |
|
103
Unilever
UL
$144B
| $588K | ﹤0.01% |
9,437
+14
| +0.1% | +$887 |
|
104
Zimmer Biomet
ZBH
$18.5B
| $543K | ﹤0.01% |
4,635
| – | – |
|
105
iShares MSCI Emerging Markets ETF
EEM
$28B
| $493K | ﹤0.01% |
10,470
| – | – |
|
106
Wells Fargo
WFC
$263B
| $491K | ﹤0.01% |
8,100
| – | – |
|
107
Procter & Gamble
PG
$347B
| $413K | ﹤0.01% |
4,499
+360
| +9% | +$32.4K |
|
108
AT&T
T
$169B
| $346K | ﹤0.01% |
11,780
| – | – |
|
109
Becton Dickinson
BDX
$45.8B
| $312K | ﹤0.01% |
1,495
+265
| +22% | +$55.5K |
|
110
Visa
V
$697B
| $308K | ﹤0.01% |
2,700
| – | – |
|
111
iShares MSCI South Korea ETF
EWY
$21.1B
| $268K | ﹤0.01% |
3,580
| – | – |
|
112
Masco
MAS
$16.5B
| $268K | ﹤0.01% |
6,100
| – | – |
|
113
International Flavors & Fragrances
IFF
$20.2B
| $244K | ﹤0.01% |
1,600
| – | – |
|
114
RTX Corp
RTX
$295B
| $242K | ﹤0.01% |
3,019
-8,236
| -73% | -$625K |
|
115
Starbucks
SBUX
$118B
| $230K | ﹤0.01% |
4,000
| – | – |
|
116
GSK
GSK
$108B
| $221K | ﹤0.01% |
4,981
-26
| -0.5% | -$1.2K |
|
117
Stryker
SYK
$133B
| $217K | ﹤0.01% |
+1,400
| New | +$214K |
|
118
Intel
INTC
$435B
| $211K | ﹤0.01% |
+4,566
| New | +$199K |
|
119
BP
BP
$107B
| $210K | ﹤0.01% |
+5,462
| New | +$198K |
|
120
Caterpillar
CAT
$387B
| $210K | ﹤0.01% |
+1,330
| New | +$184K |
|
121
Costco
COST
$429B
| $205K | ﹤0.01% |
+1,100
| New | +$190K |
|
122
M&T Bank
MTB
$36.6B
| – | – |
-1,322
| Closed | -$213K |
|
Similar funds
TI
RIM
Aristotle Capital Management's Q4 2017 Portfolio in Review
As of Q4 2017, Aristotle Capital Management held 187 positions worth $14.4B, up 12% from $12.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Aristotle Capital Management deployed $815M of net new capital in Q4 2017, opening 41 new positions and adding to 85 existing holdings. Its largest new stake was Johnson Controls International: 7,866,629 shares worth $300M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Baxter International, an estimated $407M trimmed.
- Aristotle Capital Management's largest Q4 2017 buy was Johnson Controls International: 7,866,629 shares worth $300M.
- Aristotle Capital Management added most to Amgen in Q4 2017, an estimated $120M increase.
- Aristotle Capital Management's biggest Q4 2017 reduction was Baxter International, cutting an estimated $407M.
- Aristotle Capital Management fully exited M&T Bank in Q4 2017, selling an estimated $213K.
- Aristotle Capital Management's ten largest holdings make up 31% of its $14.4B portfolio in Q4 2017.
- Aristotle Capital Management opened 41 new positions and closed 5 in Q4 2017.
- Aristotle Capital Management's portfolio value rose 12% quarter-over-quarter to $14.4B.
Based on Aristotle Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.